Esmon, 1994 - Google Patents
2 Possible involvement of cytokines in diffuse intravascular coagulation and thrombosisEsmon, 1994
View PDF- Document ID
- 125574111491465207
- Author
- Esmon C
- Publication year
- Publication venue
- Bailliere's clinical haematology
External Links
Snippet
Inflammation and the cytokines clearly affect the coagulation system. Less clear are the specific influences of the coagulation system on inflammation. In this chapter only some of the coagulation systems affected by the cytokines are discussed, and the influences on the …
- 230000015271 coagulation 0 title abstract description 50
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Esmon | Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis | |
| Esmon | The interactions between inflammation and coagulation | |
| Esmon | 2 Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis | |
| Riewald et al. | Science review: role of coagulation protease cascades in sepsis | |
| Levi | Inflammation and coagulation | |
| Esmon | The protein C anticoagulant pathway. | |
| Esmon | Inflammation and thrombosis | |
| JP3805981B2 (en) | Methods for treating hypercoagulable states or acquired protein C deficiency | |
| Esmon | The endothelial cell protein C receptor | |
| Schouten et al. | Inflammation, endothelium, and coagulation in sepsis | |
| Ten Cate et al. | The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. | |
| US5147638A (en) | Inhibition of tumor growth by blockade of the protein C system | |
| Adcock et al. | Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis | |
| FI104790B (en) | Process for Preparation of Activated Protein C | |
| Hedner | Mechanism of action, development and clinical experience of recombinant FVIIa | |
| US5120537A (en) | Factor xa based anticoagulant compositions | |
| Hertig et al. | Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury | |
| Schoenmakers et al. | Blood coagulation factors as inflammatory mediators | |
| Cimmino et al. | Role of tissue factor in the coagulation network | |
| Malý et al. | The role of tissue factor in thrombosis and hemostasis. | |
| McVEY | 3 Tissue factor pathway | |
| Dutt et al. | The yin–yang of thrombin and activated protein C | |
| Semeraro et al. | Endothelial cell perturbation and disseminated intravascular coagulation | |
| Taylor et al. | Role of the inflammatory response in the hemorrhagic syndrome induced by the hemolymph of the caterpillar Lonomia achelous | |
| WO1993009807A1 (en) | Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels |